Why Do We Screen Newborn Infants for Cystic Fibrosis?

Barben, Jürg and Southern, Kevin W (2020) Why Do We Screen Newborn Infants for Cystic Fibrosis? International journal of neonatal screening, 6 (3). 56-.

Text Why Do We Screen Newborn Infants for Cystic Fibrosis.pdf - Published version Download (150kB) | Preview

Abstract

The introduction and widespread implementation of newborn bloodspot screening (NBS) for cystic fibrosis (CF) has offered earlier diagnosis and better outcomes for children with CF in many countries of the world [...].

Item Type:	Article
Uncontrolled Keywords:	3213 Paediatrics, 32 Biomedical and Clinical Sciences, Orphan Drug, Lung, Genetic Testing, Rare Diseases, Cystic Fibrosis, Pediatric, Perinatal Period - Conditions Originating in Perinatal Period, Health Services, Genetics, Clinical Research, Prevention, 4.2 Evaluation of markers and technologies, 4.1 Discovery and preclinical testing of markers and technologies, Congenital
Depositing User:	Symplectic Admin
Date Deposited:	13 Jan 2021 11:09
Last Modified:	19 Jul 2024 00:35
DOI:	10.3390/ijns6030056
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3111902